1. Home
  2. NVCR vs DBRG Comparison

NVCR vs DBRG Comparison

Compare NVCR & DBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • DBRG
  • Stock Information
  • Founded
  • NVCR 2000
  • DBRG 1991
  • Country
  • NVCR Switzerland
  • DBRG United States
  • Employees
  • NVCR N/A
  • DBRG N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • DBRG Real Estate Investment Trusts
  • Sector
  • NVCR Health Care
  • DBRG Real Estate
  • Exchange
  • NVCR Nasdaq
  • DBRG Nasdaq
  • Market Cap
  • NVCR 2.3B
  • DBRG 1.9B
  • IPO Year
  • NVCR 2015
  • DBRG 2009
  • Fundamental
  • Price
  • NVCR $17.82
  • DBRG $8.82
  • Analyst Decision
  • NVCR Strong Buy
  • DBRG Strong Buy
  • Analyst Count
  • NVCR 4
  • DBRG 9
  • Target Price
  • NVCR $37.50
  • DBRG $16.28
  • AVG Volume (30 Days)
  • NVCR 795.3K
  • DBRG 2.6M
  • Earning Date
  • NVCR 05-01-2025
  • DBRG 04-29-2025
  • Dividend Yield
  • NVCR N/A
  • DBRG 0.45%
  • EPS Growth
  • NVCR N/A
  • DBRG N/A
  • EPS
  • NVCR N/A
  • DBRG 0.07
  • Revenue
  • NVCR $605,220,000.00
  • DBRG $595,142,000.00
  • Revenue This Year
  • NVCR $3.41
  • DBRG N/A
  • Revenue Next Year
  • NVCR $9.24
  • DBRG $9.57
  • P/E Ratio
  • NVCR N/A
  • DBRG $129.23
  • Revenue Growth
  • NVCR 18.82
  • DBRG N/A
  • 52 Week Low
  • NVCR $11.70
  • DBRG $8.63
  • 52 Week High
  • NVCR $34.13
  • DBRG $19.49
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 33.96
  • DBRG 33.45
  • Support Level
  • NVCR $18.23
  • DBRG $9.20
  • Resistance Level
  • NVCR $19.06
  • DBRG $9.58
  • Average True Range (ATR)
  • NVCR 0.80
  • DBRG 0.32
  • MACD
  • NVCR 0.02
  • DBRG -0.03
  • Stochastic Oscillator
  • NVCR 5.57
  • DBRG 14.29

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About DBRG DigitalBridge Group Inc.

DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.

Share on Social Networks: